SynthesisEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Medial quadriceps tendon-femoral ligament reconstruction for recurrent patellofemoral instability: a systematic review.
Synthesis in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRecurrent patellofemoral instability is frequent in adolescents and young adults, often associated with pain, cartilage damage, and functional impairment. While medial patellofemoral ligament (MPFL) reconstruction is considered the gold standard, it has limitations in skeletally immature patients and revision settings. Increasing attention has therefore been given to the reconstruction of medial quadriceps tendon–femoral ligament (MQTFL), a complementary stabiliser of the patella as the procedure avoids patellar bone tunnels and may reduce complications. However, current evidence on its clinical outcomes remains limited and heterogeneous, highlighting the need for systematic evaluation.
methodsThis systematic review was conducted in accordance with the 2020 PRISMA statement. PubMed, Google Scholar, EMABSE, and Web of Science were accessed in September 2025. No time constraints were used for the search. All clinical studies investigating MQTFL reconstruction, either performed in isolation or in combination with MPFL reconstruction, in patients with recurrent patellofemoral instability were considered for eligibility. The methodological quality of the included studies was assessed using the Cochrane ROBINS-I tool for non-randomised studies.
resultsData from 322 patients were included in the present analysis. The mean age was 19.7 ± 6.33 years, and 67.8% (218 of 322) were female. The Kujala score increased by 34.1 points (95% CI 25.2–43.0; P = 0.013). The Lysholm score improved by 29.4 points (95% CI 10.9–47.8; P = 0.031). The Tegner activity scale improved by 1.7 (95% CI 0.7–2.7; P = 0.006). The IKDC score improved by 31.4 points (95% CI 26.3–36.5; P = 0.008). The mean time to return to sport was 5.4 ± 1.3 months (range 4.0–6.5 months). 74% (173 of 234) of patients resumed athletic activity after MQTFL reconstruction. When considering the level of participation, 69% (50 of 72) of patients were able to return to their preinjury level. The overall complication rate was 7% (24 of 322 procedures), including subluxation (4%, 12 of 273) and dislocation (2%, 5 of 275). The rate of revision surgery for persistent symptoms or functional impairment was 2% (5 of 256 procedures).
conclusionMQTFL reconstruction is a promising surgical option for selected patients with recurrent patellofemoral instability. Its anatomical and technical advantages, particularly the avoidance of patellar bone tunnels, support its growing interest. While early clinical outcomes are encouraging, the current evidence is limited by methodological heterogeneity and small sample sizes. Further high-quality, comparative studies are needed to clarify its indications, optimise the technique, and confirm long-term efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.